Alto Neuroscience Income Statement (2023-2026) | ANRO

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 5.61M7.07M7.97M-20.45M9.95M13.18M13.06M10.80M9.97M13.12M10.53M12.00M20.29M
Selling, General & Administrative (Quarter) 1.59M2.05M1.75M2.12M4.43M5.16M5.83M6.20M5.70M5.56M4.43M5.06M6.84M
Other Operating Expenses (Quarter) 30.09M
Operating Expenses (Quarter) 7.20M9.12M9.72M11.77M14.39M18.34M18.89M17.00M15.68M18.68M14.95M17.05M27.14M
Operating Income (Quarter) -7.20M-9.12M-9.72M-11.77M-14.39M-18.34M-18.89M-17.00M-15.68M-18.68M-14.95M-17.05M-27.14M
EBIT (Quarter) -7.20M-9.12M-9.72M-11.77M-14.39M-18.34M-18.89M-17.00M-15.68M-18.68M-14.95M-17.05M-27.14M
Non-operating items
Interest & Investment Income (Quarter) 0.23M0.67M0.71M0.74M1.56M2.66M2.50M2.13M1.83M1.68M1.53M1.56M1.56M
Other Non Operating Income (Quarter) -0.68M
Non Operating Income (Quarter) -0.08M0.46M0.58M0.55M0.97M2.31M2.10M1.80M0.51M0.98M0.77M0.87M0.90M
Net income details
EBT (Quarter) -7.29M-8.79M-9.37M-11.38M-13.17M-16.03M-16.73M-15.20M-14.45M-17.64M-14.07M-16.07M-26.12M
Profit After Tax (Quarter) -7.28M-8.66M-9.14M-11.22M-13.42M-16.03M-16.78M-15.20M-15.17M-17.71M-14.18M-16.18M-26.24M
Income from Continuing Operations (Quarter) -7.29M-8.79M-9.37M-11.38M-13.17M-16.03M-16.73M-15.20M-14.45M-17.64M-14.07M-16.07M-26.12M
Consolidated Net Income (Quarter) -7.29M-8.79M-9.37M-11.38M-13.17M-16.03M-16.73M-15.20M-14.45M-17.64M-14.07M-16.07M-26.12M
Income towards Parent Company (Quarter) -7.29M-8.79M-9.37M-11.38M-13.17M-16.03M-16.73M-15.20M-14.45M-17.64M-14.07M-16.07M-26.12M
Net Income towards Common Stockholders (Quarter) -7.29M-8.79M-9.37M-11.38M-13.17M-16.03M-16.73M-15.20M-14.45M-17.64M-14.07M-16.07M-26.12M
Additional items
EPS (Basic) (Quarter) -1.97-2.33-2.44-2.98-0.76-0.60-0.62-0.56-0.56-0.65-0.52-0.45-0.80
EPS (Weighted Average and Diluted) (Quarter) -1.97-2.33-2.44-2.98-0.76-0.60-0.62-0.56-0.56-0.65-0.52-0.45-0.80
Shares Outstanding (Weighted Average) (Quarter) 3.69M3.72M3.72M3.73M17.60M22.31M26.96M24.60M27.05M27.07M27.10M28.85M32.89M
Shares Outstanding (Diluted Average) (Quarter) 3.69M3.70M3.72M3.73M17.60M22.31M23.88M24.60M27.05M27.07M27.10M28.85M32.89M
EBITDA (Quarter) -7.20M-9.12M-9.72M-11.77M-14.39M-18.34M-18.89M-17.00M-15.68M-18.68M-14.95M-17.05M-27.14M
Interest Expenses (Quarter) 0.32M0.33M0.36M0.36M0.35M0.35M0.35M0.33M0.60M0.65M0.65M0.57M0.55M